In September, the FDA approved topical ruxolitinib cream (Opzelura, Incyte) as the first JAK inhibitor to treat AD. Del Rosso noted its list of indications could expand in the near future. Recently released Phase 3 clinical trial program data shows positive outcomes for this JAK inhibitor in treating vitiligo and AA.
News Alert
New Treatment Options
RESEARCH
Resources for Dermatologist treating patients with Vitiligo in Florida
Are you looking for a dermatologist to treat your vitiligo? Are you located in Central Florida area?
Click on the link below to schedule an appointment with Dr. Seth Forman our medical advisor's practice is located in the Tampa area.
MEDIA COVERAGE
AS SEEN ON
.png)
https://www.youtube.com/watch?v=_RjyQuYtggo&t=193s June 16, 2022
Beautifully Unblemished | WFLA February 27, 2020
June 2021
June 2021
August 17, 2019
https://www.thelyfemagazine.com/tonja-johnson/
March 13, 2019
I'm a paragraph. Click here to add your own text and edit me. It's easy.